Clinical trial
Real-World Treatment Study of Koselugo (Selumetinib)
NCT06360406 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real-World Treatment Study of Koselugo (Selumetinib)
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 15, 2024
- Completion date
- September 30, 2031
- Enrollment
- 200 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.